首页> 外文OA文献 >The effect of drugs and nutraceuticals on the prevention and treatment of non-alcoholic fatty liver disease using rats as a model for humans
【2h】

The effect of drugs and nutraceuticals on the prevention and treatment of non-alcoholic fatty liver disease using rats as a model for humans

机译:以大鼠为人类模型的药物和营养保健品在预防和治疗非酒精性脂肪肝中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-alcoholic fatty liver disease (NAFLD) is defined as the accumulation of lipid in the liver with an absence of significant alcohol consumption. NAFLD is becoming increasingly recognized as a common cause of liver dysfunction and has an estimated prevalence of 17-33% in the general population of the United States. It has a close association with obesity and the metabolic syndrome as well as with cases of malnutrition and starvation. With obesity on the rise in developing countries and malnutrition plaguing underdeveloped countries, the prevalence of NAFLD worldwide is unquestionable. There are currently no recommended prevention and treatment strategies for the management of NAFLD. Many regimens have been proposed but there are few studies that directly compare their effectiveness. This thesis presents original research evaluating and comparing different dietary, pharmaceutical, and nutraceutical protocols on the prevention and treatment of NAFLD using rats as a model for humans.
机译:非酒精性脂肪肝疾病(NAFLD)的定义是在没有大量酒精消耗的情况下肝脏中脂质的积累。 NAFLD被越来越多地认为是肝功能障碍的常见原因,在美国总人口中估计患病率为17-33%。它与肥胖症和代谢综合征以及营养不良和饥饿密切相关。随着发展中国家肥胖的增加和营养不良困扰着不发达国家的发展,全球范围内NAFLD的患病率无疑是不容置疑的。目前尚无推荐的NAFLD防治策略。已经提出了许多方案,但是很少有研究可以直接比较其有效性。本文提出了以大鼠为人类模型评估和比较不同饮食,药物和营养保健品对NAFLD预防和治疗的原始研究。

著录项

  • 作者

    Allen, Portia Sueann;

  • 作者单位
  • 年度 2010
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类
  • 入库时间 2022-08-20 20:23:40

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号